Stay updated on Pembro & HER2Bi-ACT for Met CRPC Clinical Trial
Sign up to get notified when there's something new on the Pembro & HER2Bi-ACT for Met CRPC Clinical Trial page.

Latest updates to the Pembro & HER2Bi-ACT for Met CRPC Clinical Trial page
- Check4 days agoChange DetectedA site-wide NIH notice about the website transition and terminology was added, and the site revision advanced from v3.7.1 to v3.7.2. The study page itself remains a 403 Forbidden error.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe footer’s site revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating access to the study record is blocked. The previous study content and documents are no longer visible, replaced by the error message.SummaryDifference18%

- Check39 days agoChange DetectedThe page’s revision tag was updated from v3.6.6 to v3.7.0, indicating a software version update for the page. No visible changes to study details are indicated.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page's revision tag changed from v3.6.5 to v3.6.6, representing a backend/template update. This does not modify the displayed study information.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision tag updated to v3.6.5, replacing the previous v3.6.4, indicating a new site release. The update does not change the study details or other user-facing content.SummaryDifference0.1%

Stay in the know with updates to Pembro & HER2Bi-ACT for Met CRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro & HER2Bi-ACT for Met CRPC Clinical Trial page.